Picture of Enveric Biosciences logo

ENVB Enveric Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Enveric Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments1.5817.417.72.292.24
Prepaid Expenses
Total Other Current Assets
Total Current Assets2.2817.718.43.582.73
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.4710.7410.5070.306
Net Goodwill
Net Intangible Assets
Total Assets4.126.719.64.33.08
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.6812.0842.341.49
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities0.6814.414.882.341.49
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3.4222.314.71.961.59
Total Liabilities & Shareholders' Equity4.126.719.64.33.08
Total Common Shares Outstanding
Total Preferred Shares Outstanding